Literature DB >> 3384174

MHC class I antigens as surface markers of adult erythrocytes during the metamorphosis of Xenopus.

M F Flajnik1, L Du Pasquier.   

Abstract

An alloantiserum produced against Xenopus MHC class I antigens has been used to distinguish different erythrocyte populations at metamorphosis. By analysis using a fluorescence-activated cell sorter (FACS) analyzer, tadpole (stage 55) and adult erythrocytes have distinct volume differences and tadpole cells have no MHC antigens on the cell surface. Both tadpole and adult erythrocytes express a "mature erythrocyte" antigen marker, recognized by its monoclonal antibody (F1F6). During metamorphosis, immature erythrocytes, at various stages of differentiation, which express adult levels of cell-surface MHC antigens by 12 days after tail resorption, are found in the bloodstream. These immature cells are biosynthetically active, produce adult hemoglobin, and mature by 60 days after the completion of metamorphosis. Percoll gradient-density fractionation has shown that all of the cells in the new erythrocyte series express adult levels of MHC antigens but there is only a gradual increase in the amount of "mature erythrocyte" antigen. Tadpole erythrocytes, which are biosynthetically active during larval stages, produce small amounts of surface MHC antigens before the metamorphic climax and then become metabolically inactive. They are completely cleared from the circulation by 60 days after metamorphosis. Erythrocytes from tadpoles arrested in their development for long periods of time express intermediate levels of MHC antigens, suggesting a "leaky" expression of these molecules in the tadpole cells. The most abundant erythrocyte cell-surface proteins from tadpoles and adults, as judged by two-dimensional gel electrophoresis, are very different.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384174     DOI: 10.1016/0012-1606(88)90282-5

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  8 in total

Review 1.  The genus Xenopus as a multispecies model for evolutionary and comparative immunobiology of the 21st century.

Authors:  Jacques Robert; Nicholas Cohen
Journal:  Dev Comp Immunol       Date:  2011-01-28       Impact factor: 3.636

2.  IgD, like IgM, is a primordial immunoglobulin class perpetuated in most jawed vertebrates.

Authors:  Yuko Ohta; Martin Flajnik
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

3.  Susceptibility of Xenopus laevis tadpoles to infection by the ranavirus Frog-Virus 3 correlates with a reduced and delayed innate immune response in comparison with adult frogs.

Authors:  Francisco De Jesús Andino; Guangchun Chen; Zhenghui Li; Leon Grayfer; Jacques Robert
Journal:  Virology       Date:  2012-07-21       Impact factor: 3.616

Review 4.  γδ T, NKT, and MAIT Cells During Evolution: Redundancy or Specialized Functions?

Authors:  Christelle Harly; Jacques Robert; Francois Legoux; Olivier Lantz
Journal:  J Immunol       Date:  2022-07-15       Impact factor: 5.426

Review 5.  Comparative and developmental study of the immune system in Xenopus.

Authors:  Jacques Robert; Yuko Ohta
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

Review 6.  Antiviral immunity in amphibians.

Authors:  Guangchun Chen; Jacques Robert
Journal:  Viruses       Date:  2011-10-31       Impact factor: 5.818

7.  Co-option of immune effectors by the hormonal signalling system triggering metamorphosis in Drosophila melanogaster.

Authors:  Catarina Nunes; Takashi Koyama; Élio Sucena
Journal:  PLoS Genet       Date:  2021-11-29       Impact factor: 6.020

8.  Cell landscape of larval and adult Xenopus laevis at single-cell resolution.

Authors:  Yuan Liao; Lifeng Ma; Qile Guo; Weigao E; Xing Fang; Lei Yang; Fanwei Ruan; Jingjing Wang; Peijing Zhang; Zhongyi Sun; Haide Chen; Zhongliang Lin; Xueyi Wang; Xinru Wang; Huiyu Sun; Xiunan Fang; Yincong Zhou; Ming Chen; Wanhua Shen; Guoji Guo; Xiaoping Han
Journal:  Nat Commun       Date:  2022-07-25       Impact factor: 17.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.